Table 1.
Baseline characteristics of NEO study population without pre-existing CVD
| Metabolic syndrome | ||
|---|---|---|
| No (76%) | Yes (24%) | |
| Age, years | 55.3 (5.2) | 56.5 (7.9) |
| Sex, men, % | 39.9 | 52.6 |
| Ethnicity, white, % | 95 | 96 |
| BMI, kg/m2 | 25.0 (3.0) | 30.1 (6.4) |
| Smoking, % | ||
| Never | 40.8 | 33.5 |
| Former | 44.3 | 48.0 |
| Current | 14.9 | 18.5 |
| Alcohol intake, g/dag | 9.7 (3.2–20.9) | 10.4 (2.0–24.6) |
| Physical activity, MET-hour/week | 30.9 (16.9–51.0) | 25.8 (11.8–45.2) |
| Education level, low, (%)a | 16.0 | 28.0 |
| Fasting plasma glucose, mg/dL | 93.7 (88.3–98.9) | 105.7 (98.9–114.2) |
| Use of glucose lowering therapy, % | 0.6 | 7.6 |
| Systolic blood pressure (mmHg) | 127.6 (14.1) | 137.6 (22.6) |
| Diastolic blood pressure (mmHg) | 81.7 (8.5) | 87.9 (13.4) |
| Use of antihypertensive therapy, % | 14.5 | 40.3 |
| Waist circumference (cm) | ||
| Men | 94.4 (7.7) | 106.9 (13.9) |
| Women | 83.6 (9.0) | 101.1 (15.4) |
| Triglycerides, mg/dL | 78.8 (59.3–106.3) | 160.3 (111.6–208.1) |
| HDL, mg/dL | ||
| Men | 55.8 (11.0) | 43.3 (15.4) |
| Women | 71.5 (13.9) | 53.4 (18.8) |
| Use of lipid lowering therapy, % | 4.8 | 18.8 |
Data are presented as mean (SD), median (IQR) or percentage. Results were based on analyses weighted towards the BMI distribution of the general population
BMI Body Mass Index, MET metabolic equivalent of task
aLower education: none, primary school, lower vocational education